贝恩资本公司在股票下跌时出售了Emcure药品的股份. Bain Capital sells stake in Emcure Pharmaceuticals as stock falls.

贝恩资本以289亿卢比的价格出售了Emcure制药公司近1%的股权,使其持有率降至2.93%. Bain Capital sold nearly a 1% stake in Emcure Pharmaceuticals for over ₹289 crore, reducing its holding to 2.93%. 挪威政府养老基金全球购买了这些股票,导致Emcure的股价下跌2.31%. Norway’s Government Pension Fund Global bought the shares, causing Emcure’s stock to fall 2.31%. 公司报告称,截至2025年12月31日的季度合并利增长了48%. The company reported a 48% increase in consolidated profit for the quarter ended December 31, 2025.